908 Devices (MASS) Other financing activities (2021 - 2026)
908 Devices (MASS) reported Other financing activities of $121000.0 for Q1 2026, up 8.04% on a QoQ basis from $112000.0 in Q1 2022.
908 Devices (MASS) has 3 years of Other financing activities data on file, last reported at $121000.0 in Q1 2026.
- Quarterly Other financing activities changed N/A year-over-year to $121000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121000.0 (changed N/A YoY) and the FY2022 annual result came in at $112000.0, down 86.67% from the prior year.
- Other financing activities grew to $121000.0 in Q1 2026 per MASS's latest filing, from $112000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $121000.0 in Q1 2026 and bottomed at $112000.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121,000.00 |
| Mar 31, 2026 | 121,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 801,000.00 |
| Dec 31, 2021 | 801,000.00 |
| Sep 30, 2021 | -537,000.00 |
| Sep 30, 2021 | -537,000.00 |
| Jun 30, 2021 | 559,000.00 |
| Jun 30, 2021 | 559,000.00 |
| Mar 31, 2021 | 17,000.00 |
| Mar 31, 2021 | 17,000.00 |